These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35543105)

  • 1. Neuropsychiatric symptoms in post-COVID-19 long haulers.
    Alghamdi HY; Alrashed AM; Jawhari AM; Abdel-Moneim AS
    Acta Neuropsychiatr; 2022 Dec; 34(6):318-329. PubMed ID: 35543105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5-11 years.
    Aldè M; Di Berardino F; Ambrosetti U; Barozzi S; Piatti G; Zanetti D; Pignataro L; Cantarella G
    Am J Otolaryngol; 2023; 44(1):103669. PubMed ID: 36283164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
    Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
    [No Abstract]   [Full Text] [Related]  

  • 5. Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses.
    Caponio VCA; Lipsi MR; Fortunato F; Arena F; Lo Muzio L
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.
    Trachootham D; Thongyen S; Lam-Ubol A; Chotechuang N; Pongpirul W; Prasithsirikul W
    Int J Infect Dis; 2021 May; 106():329-337. PubMed ID: 33819604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otolaryngological symptoms in COVID-19.
    Elibol E
    Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1233-1236. PubMed ID: 32875391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine.
    Huhn G; Poorbaugh J; Zhang L; Beasley S; Nirula A; Brothers J; Welbel S; Wilson J; Gillani S; Weber KM; Morack R; Keckler K; Benschop RJ
    PLoS One; 2022; 17(9):e0273323. PubMed ID: 36083883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-Control Study of Long COVID, Sapporo, Japan.
    Asakura T; Kimura T; Kurotori I; Kenichi K; Hori M; Hosogawa M; Saijo M; Nakanishi K; Iso H; Tamakoshi A
    Emerg Infect Dis; 2023 May; 29(5):956-966. PubMed ID: 37044126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
    Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
    BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
    AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
    J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination.
    Elmazny A; Magdy R; Hussein M; Elsebaie EH; Ali SH; Abdel Fattah AM; Hassan M; Yassin A; Mahfouz NA; Elsayed RM; Fathy W; Abdel-Hamid HM; Abdelbadie M; Soliman SH
    Eur Arch Psychiatry Clin Neurosci; 2023 Sep; 273(6):1349-1358. PubMed ID: 36707454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort.
    Kopplin N; Garcia A; Reczek A; Wilkinson K; Yekkaluri S; Murphy CC; Tiro J; Muthukumar AR; Masica A; Singal AG
    PLoS One; 2023; 18(9):e0291259. PubMed ID: 37682916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Loss of Smell and Loss of Taste in COVID-19 Infected Patients.
    Shrestha S; Paudel A; Shrestha S; Gautam A; Bhurtel M; Adhikari P
    J Nepal Health Res Counc; 2022 Jun; 20(1):84-88. PubMed ID: 35945858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
    Lee Y; Min P; Lee S; Kim SW
    J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
    Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
    Front Immunol; 2022; 13():863554. PubMed ID: 35711445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Positive Severe Acute Respiratory Syndrome Coronavirus Polymerase Chain Reaction After Coronavirus Disease 2019 Vaccination With up to 8 Months of Follow-up: Real-life Data From the Capital Region of Denmark.
    Heftdal LD; Schultz M; Lange T; Knudsen AD; Fogh K; Hasselbalch RB; Linander CB; Kallemose T; Bundgaard H; Grønbæk K; Valentiner-Branth P; Iversen K; Nielsen SD
    Clin Infect Dis; 2022 Aug; 75(1):e675-e682. PubMed ID: 35015858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.